6thMarch 2019, Florida-The global rabies diagnostics market size will be worth USD 5.1Billion by 2026, according to a new research study published by Ameri Research. The factors driving the market growth include increase in number of dog bites, supportive government laws and rising investment in R&D to introduce new products.
Rabies Diagnostics is an infectious disease caused by the virus in both human and animal body, with the sample test of spinal fluid, serum, saliva, and skin biopsies of hair follicles at the part of spinal fluid, Neck, and serum. The diagnostics test will be held before the death of the body. Most widely used primary diagnostics test for rabies in humans and animals’ fluorescent antibody test. Rabies virus comes to family genus lyssavirus, serotype 1, and Rhabdoviridae. This virus transmitted to human by the bite of a rabid animal. Rabies Diagnostics test is available wide ranges in the subject to cost and efficiency. There is many commercial and conventional stain test are available, but their test is not equal to the national laboratory test. To detect this type of Rabies virus only WHO and OIE recommended standard laboratory tests way to identify a reliable diagnosis of rabies. In that laboratory only positive test results are valid.
We observed that the rapid growth of Rabies Diagnostics market byELISA/Immunohistochemistry having the largest market share of the global market which expected to be the fastest growing device over the forecast period. Because this test having a light microscope, cost-effective, and less time-consuming.
Click the link below to view the report description:
https://www.ameriresearch.com/product/rabies-diagnostics-market/
Key findings from the study: –
- Rabies Diagnostics is an infectious disease caused by the virus in both human and animal body, with the sample test of spinal fluid, serum, saliva, and skin biopsies of hair follicles at the part of spinal fluid, Neck, and serum. The diagnostics test will be held before the death of the body.
- We have segmented the Global Rabies Diagnostics based on Diagnostic method as Fluorescent antibody test (FAT), Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Test.
- We have segmented the Global Rabies Diagnostics market based on Technology type ELISA/Immunohistochemistry, Chromatography Techniques, PCR, and Other Technologies.
- The key market participants include Bio-Rad Laboratories, Aviva Systems Biology Corporation Merck, KGaA, Demeditec Diagnostics GmbH, Creative Diagnostics, NorgenBiotek Corp., Abbexa Ltd., Express Biotech International Inc., BioNote, Inc., and MyBioSource.
Ameri Research has segmented the Global Rabies Diagnostics Market byend diagnostic method, technology, and region:
- Global Rabies Diagnostics Market by Diagnostic Method (Revenue, Million, 2018 – 2026)
- Fluorescent antibody test (FAT)
- Immunohistochemical Test
- Amplification Methods
- Histologic Examination
- Serology Tests
- Global Rabies Diagnostics Market by Key Technology(Revenue, Million, 2018 – 2026)
- ELISA/Immunohistochemistry
- Chromatography Techniques
- PCR
- Other Technologies
Global Rabies Diagnostics Market Regional Outlook (Revenue, USD Million, 2018-2026)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Australia
- Latin America
- Brazil
- Mexico
- Columbia
- Middle East and Africa
- South Africa
- Saudi Arabia
Global Rabies Diagnostics Market,Global Rabies Diagnostics Market Analytics,Global Rabies Diagnostics Market Share, Global Rabies Diagnostics Market Research,Global Rabies Diagnostics Market Forecast,Global Rabies Diagnostics Market Insight, Global Rabies Diagnostics Market Trend, Global Rabies Diagnostics Market Value,Global Rabies Diagnostics Market Size, Global Rabies Diagnostics Market Analysis,Global Rabies Diagnostics Market Survey,Global Rabies Diagnostics Market Research Report